Indian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container defect. The recall was made after leakage was observed through the inhaler valve of one single inhaler. All six batches, produced using the same lot of valves in November 2021, are being recalled.
